TFS
CKPT

TrustCore Financial Services’s Checkpoint Therapeutics CKPT Stock Holding History

TrustCore Financial Services’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$792 Hold
155
– – ﹤0.01% 948
2022
Q3 		$2K Hold
155
– – ﹤0.01% 951
2022
Q2 		$2K Hold
155
– – ﹤0.01% 936
2022
Q1 		$3K Hold
155
– – ﹤0.01% 907
2021
Q4 		$5K Hold
155
– – ﹤0.01% 789
2021
Q3 		$5K Hold
155
– – ﹤0.01% 860
2021
Q2 		$5K Hold
155
– – ﹤0.01% 832
2021
Q1 		$5K Buy
+155
New +$5.2K ﹤0.01% 783

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TrustCore Financial Services's CKPT Position: Q4 2022 in Review

TrustCore Financial Services held its Checkpoint Therapeutics (CKPT) position steady in Q4 2022 at 155 shares worth $792. The position accounts for ﹤0.01% of the portfolio, ranked #948.

TrustCore Financial Services first reported a position in CKPT in Q1 2021 and has held it in 8 quarters since. The position peaked at $5K in Q4 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • TrustCore Financial Services held 155 shares of Checkpoint Therapeutics worth $792 as of Q4 2022.
  • TrustCore Financial Services left its Checkpoint Therapeutics share count unchanged in Q4 2022.
  • Checkpoint Therapeutics made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #948 holding.
  • TrustCore Financial Services first reported a position in Checkpoint Therapeutics in Q1 2021 and has held it in 8 quarters since.
  • TrustCore Financial Services's Checkpoint Therapeutics position peaked at $5K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.